{"disease":{"id":"cervical-dystonia","name":"Cervical Dystonia","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":3},"drugs":{"marketed":[{"drug_id":"onabotulinumtoxina","indication_name":"Cervical Dystonia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Botox","generic_name":"ONABOTULINUMTOXINA","company_name":"Allergan","drug_phase":"marketed","molecular_target":"SNAP-25","drug_class":"Acetylcholine Release Inhibitor [EPC]","quality_score":60,"revenue":"5300","mechanism":"BOTOX blocks neuromuscular transmission by inhibiting acetylcholine release through cleavage of SNAP-25."},{"drug_id":"onabotulinumtoxina","indication_name":"Cervical Dystonia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Botox","generic_name":"ONABOTULINUMTOXINA","company_name":"Allergan","drug_phase":"marketed","molecular_target":"SNAP-25","drug_class":"Acetylcholine Release Inhibitor [EPC]","quality_score":60,"revenue":"5300","mechanism":"BOTOX blocks neuromuscular transmission by inhibiting acetylcholine release through cleavage of SNAP-25."},{"drug_id":"botulinum-toxin","indication_name":"Cervical Dystonia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Botulinum Toxin","company_name":"University Health Network, Toronto","drug_phase":"marketed","molecular_target":"","drug_class":"Acetylcholine Release Inhibitor [EPC]","quality_score":10,"revenue":null,"mechanism":null},{"drug_id":"incobotulinumtoxina","indication_name":"Cervical dystonia in adults","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xeomin","generic_name":"INCOBOTULINUMTOXINA","company_name":"Merz Pharms","drug_phase":"marketed","molecular_target":"","drug_class":"Acetylcholine Release Inhibitor [EPC]","quality_score":55,"revenue":null,"mechanism":"Xeomin works by blocking the release of a chemical messenger called acetylcholine, which signals muscles to contract."},{"drug_id":"rimabotulinumtoxinb","indication_name":"Cervical Dystonia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Myobloc","generic_name":"RIMABOTULINUMTOXINB","company_name":"Elan Pharm","drug_phase":"marketed","molecular_target":"","drug_class":"Acetylcholine Release Inhibitor [EPC]","quality_score":53,"revenue":null,"mechanism":"Myobloc works by blocking the release of acetylcholine, a chemical messenger that signals muscles to contract."},{"drug_id":"incobotulinumtoxina","indication_name":"Cervical dystonia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xeomin","generic_name":"INCOBOTULINUMTOXINA","company_name":"Merz Pharms","drug_phase":"marketed","molecular_target":"","drug_class":"Acetylcholine Release Inhibitor [EPC]","quality_score":55,"revenue":null,"mechanism":"Xeomin works by blocking the release of a chemical messenger called acetylcholine, which signals muscles to contract."}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02175693","title":"Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition and Safety in Patients With Cervical Dystonia","phase":"","overall_status":"COMPLETED","enrollment_count":1647,"lead_sponsor_name":"Eisai Co., Ltd.","has_results":false},{"nct_id":"NCT03617367","title":"Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":357,"lead_sponsor_name":"Revance Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03608397","title":"Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":301,"lead_sponsor_name":"Revance Therapeutics, Inc.","has_results":false},{"nct_id":"NCT01486264","title":"Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":283,"lead_sponsor_name":"Merz Pharmaceuticals GmbH","has_results":true},{"nct_id":"NCT05884528","title":"Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia","phase":"","overall_status":"COMPLETED","enrollment_count":270,"lead_sponsor_name":"Merz Therapeutics GmbH","has_results":false},{"nct_id":"NCT03905304","title":"Efficacy and Safety of MEDITOXIN® in Cervical Dystonia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":152,"lead_sponsor_name":"Medy-Tox","has_results":false},{"nct_id":"NCT02175719","title":"Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition in Patients With Change From Botulinum Toxin Type A","phase":"","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Eisai Co., Ltd.","has_results":false},{"nct_id":"NCT06937931","title":"A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":132,"lead_sponsor_name":"Ipsen","has_results":false},{"nct_id":"NCT03946046","title":"Targeting Methods of Botulinum Toxin Injections for Cervical Dystonia","phase":"NA","overall_status":"COMPLETED","enrollment_count":132,"lead_sponsor_name":"University Hospital, Lille","has_results":false},{"nct_id":"NCT05103202","title":"Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin","phase":"","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":false},{"nct_id":"NCT05715138","title":"Comparison of Pallidal With Subthalamic Deep Brain Stimulation for Cervical Dystonia","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":98,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT06830642","title":"Study of the Oral Treatment MTR-601 in Cervical Dystonia","phase":"PHASE2","overall_status":"SUSPENDED","enrollment_count":80,"lead_sponsor_name":"Motric Bio","has_results":false},{"nct_id":"NCT04849988","title":"A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"AEON Biopharma, Inc.","has_results":true},{"nct_id":"NCT02504905","title":"Propensity to Develop Plasticity in the Parieto-Motor Networks in Dystonia From the Perspective of Abnormal High-Order Motor Processing","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT03805152","title":"Abobotulinum Toxin and Neubotulinum Toxin Injection in Cerivical Dystonia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Department of Medical Services Ministry of Public Health of Thailand","has_results":false},{"nct_id":"NCT04871451","title":"Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical Dystonia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"AEON Biopharma, Inc.","has_results":true},{"nct_id":"NCT04582929","title":"Neubotulinum Toxin Injection in Cerivical Dystonia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Department of Medical Services Ministry of Public Health of Thailand","has_results":false},{"nct_id":"NCT06328114","title":"Accelerating TMS for Cervical Dystonia","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":50,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT04432285","title":"Long-term Outcome of DBS Versus Botulinum Toxin Treatment in Cervical Dystonia","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Oslo University Hospital","has_results":false},{"nct_id":"NCT06881147","title":"Physiotherapy and Botox for Cervical Dystonia: Impact of Sensory Tricks and Brain Imaging Insights","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":49,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT06886750","title":"The Effects of Waning of Botulinum Toxin in the Treatment of Cervical Dystonia","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":45,"lead_sponsor_name":"Western University, Canada","has_results":false},{"nct_id":"NCT00323765","title":"Plasticity in Cervical Dystonia","phase":"","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT04949594","title":"Relief of Pain in Patients With Cervical Dystonia Through the Use of Transcutaneous Electric Nerve Stimulation (TENS)","phase":"","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT02959645","title":"Assessment of Brain Activities in Cervical Dystonia","phase":"","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT03938363","title":"Analysis of Gait Before and After Botulinum Toxin Treatment in Patients With Focal Dystonia","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"University Hospital, Grenoble","has_results":false},{"nct_id":"NCT04171258","title":"Clinical Trial to Compare the Safety and Efficacy of Botulax® Versus Botox® in Patients With Cervical Dystonia","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Hugel","has_results":false},{"nct_id":"NCT03369613","title":"Transcranial Electrical Stimulation for Cervical Dystonia","phase":"NA","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT02877836","title":"Functional MRI and DTI in the Preoperative Assessment of Dystonia","phase":"NA","overall_status":"TERMINATED","enrollment_count":36,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT03471923","title":"Non-Motor Features of Cervical Dystonia (CD)","phase":"","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT02689466","title":"Cholinergic Receptor Imaging in Dystonia","phase":"","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT06748846","title":"Segmental Muscle Vibration on Pain in Patients With Primary Cervical Dystonia","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":28,"lead_sponsor_name":"Fondazione Don Carlo Gnocchi Onlus","has_results":false},{"nct_id":"NCT03969537","title":"Telemedicine Follow-up for Patients With Cervical Dystonia Treated With Neurotoxin Injections","phase":"","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT02131467","title":"Safety and Tolerability of Perampanel in Cervical Dystonia","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT02894359","title":"Computer Modelling of the Cervical Spine Movements in Cervical Dystonia","phase":"","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Fondation Ophtalmologique Adolphe de Rothschild","has_results":false},{"nct_id":"NCT05327985","title":"Three-dimensional Analysis of Obliquus Capitis Inferior Muscle Function in the Rotatory Form of Cervical Dystonia","phase":"","overall_status":"TERMINATED","enrollment_count":21,"lead_sponsor_name":"Fondation Ophtalmologique Adolphe de Rothschild","has_results":false},{"nct_id":"NCT05157100","title":"Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"The Orthopedic Foundation","has_results":false},{"nct_id":"NCT07014384","title":"Cerebellar Transcranial Direct Current Stimulation (tDCS) in Patients With Isolated Cervical Dystonia (CD)","phase":"NA","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT03247868","title":"A Multimodal Approach to Cervical Dystonia Treatment With Association of Botulinum Toxin and Motor Learning Techniques","phase":"NA","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Fondazione Don Carlo Gnocchi Onlus","has_results":false},{"nct_id":"NCT07140874","title":"Zinc as an Adjunctive Therapy for Cervical Dystonia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"University of Florida","has_results":false},{"nct_id":"NCT04916444","title":"Dystonia Treatment With Injections Supplemented By Transcranial Magnetic Stimulation","phase":"NA","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"University of Florida","has_results":true},{"nct_id":"NCT03041714","title":"Neurophysiologic Study of Patient With Essential Tremor and Dystonic Tremor","phase":"","overall_status":"COMPLETED","enrollment_count":2,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false}],"total":41},"guidelines":[],"source":"Drug Landscape verified database"}